Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-29

Clinical Trial Update: Efficacy and Feasibility of Ectoin® Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung [NA]

View source ↗

Summary

A completed clinical trial from Bitop AG assessed the efficacy and feasibility of inhaled Ectoin Inhalation Solution for COPD and particulate matter–induced lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ectoin Inhalation Solution (ectoine)

Snippet

Sponsor: Bitop AG | Conditions: COPD, Particulate Matter Induced Inflammation of the Lung | NA | Status: COMPLETED